Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eyes are on the rollout of Lilly's new weight loss pill.

The GLP-1 drug market is massive and still growing fast. Investing in a promising growth stock in the space could lead to significant returns.

Eli Lilly draws fresh market attention as healthcare rotation, GLP treatment access, and obesity care demand strengthen its ...

Eli Lilly and Co. LLY is phasing out select insulin products across parts of Europe for commercial reasons, with regulators emphasizing that the move is not linked to safety or quality concerns. The ...

The pharma titan is expanding into new markets.

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

NEW YORK/LONDON, June 10 (Reuters) - Eli Lilly (LLY.N), opens new tab has solidified its leading position in the booming market for obesity drugs ahead of a wave of possible new entrants to the space.